Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Simon J. Hocart"'
Autor:
Nieves González, David H. Coy, Robert T. Jensen, Tomoo Nakagawa, Simon J. Hocart, Hirotsugu Uehara, Tatsuro Katsuno, Samuel A. Mantey
Publikováno v:
Biochemical Pharmacology. 84:936-948
There is increased interest in the Bn-receptor family because they are frequently over/ectopically expressed by tumors and thus useful as targets for imaging or receptor-targeted-cytotoxicity. The synthetic Bn-analog, [D-Tyr(6), β-Ala(11), Phe(13),
Autor:
Richard V. Benya, Michael Schumann, David Venzon, Tomoo Nakagawa, Simon J. Hocart, Robert T. Jensen, Kenji Tokita, Samuel A. Mantey
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 307:597-607
Little is known about the function of the central portion of the second intracellular loop (i2 loop) of peptide receptors in activation of downstream pathways and receptor modulatory processes such as receptor internalization or chronic down-regulati
Autor:
Robert T. Jensen, Tetsuhide Ito, David H. Coy, Simon J. Hocart, Charles D. Ulrich, Samuel A. Mantey, Tapas K. Pradhan, Hisato Igarashi, Wei Hou
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 301:37-50
Vasoactive intestinal peptide (VIP) is a neurotransmitter involved in a number of pathological and physiological processes. VIP is rapidly degraded and simplified stable analogs are needed. VIP's action was extensively studied in rat and guinea pig.
Publikováno v:
Journal of Medicinal Chemistry. 44:1305-1311
The search for synthetic peptide analogues of somatostatin (SRIF) which exhibit selective affinities for the five known receptor subtypes (sst1-5) has generated a large number of potent agonists. Some of these agonists display good subtype selectivit
Autor:
Tatsuro Katsuno, Kenji Tokita, Robert T. Jensen, Simon J. Hocart, Samuel A. Mantey, David H. Coy
Publikováno v:
Journal of Biological Chemistry. 276:495-504
Peptoid antagonists are increasingly being described for G protein-coupled receptors; however, little is known about the molecular basis of their binding. Recently, the peptoid PD168368 was found to be a potent selective neuromedin B receptor (NMBR)
Publikováno v:
Journal of Medicinal Chemistry. 38:1974-1989
Somatostatin is a hypothalamic hormone that inhibits the release of growth hormone (GH). It has also been shown to inhibit the release of a broad range of hormones including insulin, glucagon, and gastrin. Presently, five different receptor subtypes
Autor:
Haiyan Deng, Donald J. Krogstad, Huayin Liu, Dibyendu De, Frances M. Krogstad, Simon J. Hocart
Chloroquine (CQ) is a safe and economical 4-aminoquinoline (AQ) antimalarial. However, its value has been severely compromised by the increasing prevalence of CQ resistance. This study examined 108 AQs, including 68 newly synthesized compounds. Of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca17cfc66115aaa2a3ec2faa1f94966
https://europepmc.org/articles/PMC3088224/
https://europepmc.org/articles/PMC3088224/
Publikováno v:
European Journal of Pharmacology. 204:179-185
Enhancement of the amphiphilic α-helical properties of the central and C-terminal regions of growth hormone-releasing hormone (GRH) by substitution with helix-favouring amino acids, particularly Ala, can result in significant improvements in GH-rele
Publikováno v:
Bioorganicmedicinal chemistry letters. 14(9)
A series of novel 1,4-diaryl-2-azetidinones was prepared by stereospecific Staudinger reaction as conformationally restricted analogues of combretastatin A-4 because molecular modeling studies suggested close geometric similarities. They were evaluat
Publikováno v:
Molecular pharmacology. 61(6)
The mammalian bombesin peptides [gastrin-releasing peptide (GRP) and neuromedin B (NMB)] are important in numerous biological and pathological processes. These effects are mediated by the heptahelical GRP receptor (GRPR) and NMB receptor (NMBR). GRP